IL146104A0 - Substituted bicyclic heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing the same - Google Patents

Substituted bicyclic heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing the same

Info

Publication number: IL146104A0
Authority: IL; Israel
Prior art keywords: processes; preparation; pharmaceutical compositions; same; compositions containing
Prior art date: 1999-04-28

Application number

IL14610400A

Other languages

English (en)

Original Assignee

Reddy Research Foundation

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-04-28

Filing date

2000-04-25

Publication date

2002-07-25

2000-04-25 Application filed by Reddy Research Foundation filed Critical Reddy Research Foundation

2002-07-25 Publication of IL146104A0 publication Critical patent/IL146104A0/xx

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
- A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
- C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
- C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
- C07D279/16—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmacology & Pharmacy (AREA)
Engineering & Computer Science (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Diabetes (AREA)
Physical Education & Sports Medicine (AREA)
Obesity (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Rheumatology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Endocrinology (AREA)
Neurology (AREA)
Urology & Nephrology (AREA)
Reproductive Health (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Pregnancy & Childbirth (AREA)
Dermatology (AREA)
Psychiatry (AREA)
Ophthalmology & Optometry (AREA)
Gynecology & Obstetrics (AREA)
Hospice & Palliative Care (AREA)
Child & Adolescent Psychology (AREA)
Vascular Medicine (AREA)
Emergency Medicine (AREA)
Pain & Pain Management (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

IL14610400A 1999-04-28 2000-04-25 Substituted bicyclic heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing the same IL146104A0 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
IN484MA1999		1999-04-28
PCT/IB2000/000501 WO2000066572A1 (fr)	1999-04-28	2000-04-25	Heterocycles bicycliques substitues, procede pour leur preparation et leur utilisation comme agents contre l'obesite et comme agents hypocholesterolemiques

Publications (1)

Publication Number	Publication Date
IL146104A0 true IL146104A0 (en)	2002-07-25

Family

ID=11095336

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL14610400A IL146104A0 (en)	1999-04-28	2000-04-25	Substituted bicyclic heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing the same

Country Status (25)

Country	Link
US (1)	US7348426B1 (fr)
EP (1)	EP1175412A1 (fr)
JP (1)	JP2002543194A (fr)
KR (1)	KR100610578B1 (fr)
CN (1)	CN1353699A (fr)
AU (1)	AU781079B2 (fr)
BG (1)	BG106146A (fr)
BR (1)	BR0010139A (fr)
CA (1)	CA2371757A1 (fr)
CZ (1)	CZ20013832A3 (fr)
EE (1)	EE200100540A (fr)
HR (1)	HRP20010785A2 (fr)
HU (1)	HUP0600105A3 (fr)
IL (1)	IL146104A0 (fr)
MX (1)	MXPA01010916A (fr)
NO (1)	NO320805B1 (fr)
NZ (1)	NZ515284A (fr)
PL (1)	PL351987A1 (fr)
RU (1)	RU2278114C2 (fr)
SK (1)	SK15092001A3 (fr)
TR (1)	TR200103848T2 (fr)
UA (1)	UA73501C2 (fr)
WO (1)	WO2000066572A1 (fr)
YU (1)	YU75101A (fr)
ZA (1)	ZA200108733B (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU2002212672A1 (en) *	2000-10-12	2002-04-22	Dr. Reddy's Research Foundation	Salts of benzothiazine and benzoxazine derivatives and pharmaceutical compositions containing them
CN1558897A (zh) *	2001-08-29	2004-12-29	��-��ع�˾	口服抗糖尿病剂
WO2003024944A1 (fr) *	2001-09-20	2003-03-27	Dr. Reddy's Laboratories Ltd.	Procede ameliore de preparation de composes antidiabetiques bicycliques
WO2003027084A1 (fr) *	2001-09-25	2003-04-03	Dr. Reddy's Laboratories Ltd.	Perfectionnement d'un procede d'elaboration de derives phenoxazine optiquement actifs utilisables comme agents antidiabetiques
IL161431A0 (en) *	2001-10-16	2004-09-27	Reddys Lab Ltd Dr	beta-PHENYL-alpha-OXYSUBSTITUTED PROPIONIC ACID DERIVATIVES, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME
WO2003066612A1 (fr) *	2002-02-07	2003-08-14	Dr. Reddy's Laboratories Limited	Nouvelles formes polymorphes d'agents bicycliques antidiabetiques, leur procede de preparation et compositions pharmaceutiques les contenant
US6716842B2 (en)	2002-04-05	2004-04-06	Warner-Lambert Company, Llc	Antidiabetic agents
KR100841165B1 (ko) *	2002-04-30	2008-06-24	유씨비 파마, 에스.에이.	2,6-퀴놀리닐 및 2,6-나프틸 유도체, 이의 제조 방법 및ｖｌａ-4 억제제로서의 용도
WO2003099800A1 (fr) *	2002-05-23	2003-12-04	Dr. Reddy's Laboratories Limited	Procede ameliore pour la preparation d'agents antidiabetiques bicycliques
WO2004041275A1 (fr)	2002-11-08	2004-05-21	F. Hoffmann-La Roche Ag	Derives de 4-alcoxyoxazole substitues en tant qu'agonistes des recepteurs ppar
US7262303B2 (en) *	2003-09-29	2007-08-28	Hoffman-La Roche Inc.	Process for the production of chiral propionic acid derivatives
DE202004002953U1 (de) *	2004-02-26	2004-04-29	Winkler, Wilhelm	Verbindungseinheit
US7579360B2 (en)	2005-06-09	2009-08-25	Bristol-Myers Squibb Company	Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
CA2610800A1 (fr)	2005-06-09	2006-12-14	Ucb Pharma, S.A.	Derives de 2,6-quinolinyle, procedes d'elaboration et leur utilisation comme medicaments
US7572807B2 (en)	2005-06-09	2009-08-11	Bristol-Myers Squibb Company	Heteroaryl 11-beta-hydroxysteroid dehydrogenase type I inhibitors
US8119658B2 (en)	2007-10-01	2012-02-21	Bristol-Myers Squibb Company	Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitors
RU2684779C2 (ru) *	2016-02-05	2019-04-15	АО "Институт химических наук им. А.Б. Бектурова"	Применение производного бета-морфолинопропиоамидоксима в качестве противодиабетического средства
CN110092774B (zh) *	2018-01-29	2022-04-08	中国科学院上海药物研究所	芳香丙酸类衍生物、及其制备方法和用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DK173350B1 (da)	1985-02-26	2000-08-07	Sankyo Co	Thiazolidinderivater, deres fremstilling og farmaceutisk paæparat indeholdende dem
GB9027023D0 (en) *	1990-12-12	1991-01-30	Wellcome Found	Anti-atherosclerotic aryl compounds
GB9225386D0 (en) *	1992-12-04	1993-01-27	Smithkline Beecham Plc	Novel compounds
WO1996004261A1 (fr)	1994-07-29	1996-02-15	Smithkline Beecham Plc	Benzoxoazoles et derives de pryridine destines a etre utilises pour le traitement du diabete tardif
JPH0912575A (ja)	1995-06-28	1997-01-14	Sankyo Co Ltd	ベンゾオキサジンおよびベンゾチアジン誘導体
GB9600464D0 (en) *	1996-01-09	1996-03-13	Smithkline Beecham Plc	Novel method
WO1997028149A1 (fr) *	1996-02-02	1997-08-07	Merck & Co., Inc.	Procede pour augmenter les niveaux de cholesterol hdl
GB9604242D0 (en) *	1996-02-28	1996-05-01	Glaxo Wellcome Inc	Chemical compounds
GB9606805D0 (en) *	1996-03-30	1996-06-05	Glaxo Wellcome Inc	Medicaments
WO1998002159A1 (fr) *	1996-07-12	1998-01-22	Smithkline Beecham Plc	Nouveau traitement contre la resistance a la leptine
AU752059B2 (en) *	1997-10-27	2002-09-05	Dr. Reddy's Laboratories Limited	Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them
WO1999020614A1 (fr) *	1998-05-27	1999-04-29	Dr. Reddy's Research Foundation	Composes bicycliques, procede de preparation et compositions pharmaceutiques les contenant
US6265401B1 (en) *	1997-10-27	2001-07-24	Reddy-Cheminor, Inc.	Bicyclic compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them

2000
- 2000-04-25 SK SK1509-2001A patent/SK15092001A3/sk unknown
- 2000-04-25 KR KR1020017013604A patent/KR100610578B1/ko not_active IP Right Cessation
- 2000-04-25 EP EP00919081A patent/EP1175412A1/fr not_active Withdrawn
- 2000-04-25 US US09/959,093 patent/US7348426B1/en not_active Expired - Fee Related
- 2000-04-25 NZ NZ515284A patent/NZ515284A/xx unknown
- 2000-04-25 WO PCT/IB2000/000501 patent/WO2000066572A1/fr not_active Application Discontinuation
- 2000-04-25 CN CN00808424A patent/CN1353699A/zh active Pending
- 2000-04-25 RU RU2001132085/04A patent/RU2278114C2/ru not_active IP Right Cessation
- 2000-04-25 EE EEP200100540A patent/EE200100540A/xx unknown
- 2000-04-25 TR TR2001/03848T patent/TR200103848T2/xx unknown
- 2000-04-25 CZ CZ20013832A patent/CZ20013832A3/cs unknown
- 2000-04-25 UA UA2001118039A patent/UA73501C2/uk unknown
- 2000-04-25 YU YU75101A patent/YU75101A/sh unknown
- 2000-04-25 PL PL00351987A patent/PL351987A1/xx not_active Application Discontinuation
- 2000-04-25 AU AU39831/00A patent/AU781079B2/en not_active Ceased
- 2000-04-25 BR BR0010139-7A patent/BR0010139A/pt not_active IP Right Cessation
- 2000-04-25 IL IL14610400A patent/IL146104A0/xx unknown
- 2000-04-25 HU HU0600105A patent/HUP0600105A3/hu unknown
- 2000-04-25 CA CA002371757A patent/CA2371757A1/fr not_active Abandoned
- 2000-04-25 MX MXPA01010916A patent/MXPA01010916A/es active IP Right Grant
- 2000-04-25 JP JP2000615602A patent/JP2002543194A/ja not_active Withdrawn
2001
- 2001-10-23 ZA ZA200108733A patent/ZA200108733B/en unknown
- 2001-10-24 HR HR20010785A patent/HRP20010785A2/hr not_active Application Discontinuation
- 2001-10-26 NO NO20015259A patent/NO320805B1/no unknown
- 2001-11-26 BG BG106146A patent/BG106146A/bg unknown

Also Published As

Publication number	Publication date
SK15092001A3 (sk)	2002-05-09
BR0010139A (pt)	2004-03-02
EP1175412A1 (fr)	2002-01-30
UA73501C2 (en)	2005-08-15
CZ20013832A3 (cs)	2002-04-17
MXPA01010916A (es)	2002-06-21
BG106146A (bg)	2002-05-31
YU75101A (sh)	2005-07-19
HUP0600105A2 (en)	2006-05-29
EE200100540A (et)	2002-12-16
US7348426B1 (en)	2008-03-25
AU3983100A (en)	2000-11-17
HRP20010785A2 (en)	2003-02-28
KR20010113891A (ko)	2001-12-28
JP2002543194A (ja)	2002-12-17
AU781079B2 (en)	2005-05-05
WO2000066572A1 (fr)	2000-11-09
RU2278114C2 (ru)	2006-06-20
TR200103848T2 (tr)	2002-04-22
NZ515284A (en)	2004-12-24
NO20015259L (no)	2001-11-15
PL351987A1 (en)	2003-07-14
ZA200108733B (en)	2003-01-23
NO320805B1 (no)	2006-01-30
KR100610578B1 (ko)	2006-08-09
CA2371757A1 (fr)	2000-11-09
NO20015259D0 (no)	2001-10-26
HUP0600105A3 (en)	2006-11-28
CN1353699A (zh)	2002-06-12

Publication	Publication Date	Title
PL350522A1 (en)	2002-12-16	Bicyclic heterocycles, pharmaceutical compositions containing these compounds, and processes for preparing them
IL145013A0 (en)	2002-06-30	Tricyclic compounds, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0203142A3 (en)	2003-03-28	Benzodiazepine derivatives, process for preparation of the compounds, pharmaceutical compositions containing them and their use
HUP0201900A3 (en)	2003-02-28	Bicyclic heterocycles, pharmaceutical compositions containing them, their use and methods for the production thereof
HUP0201376A2 (en)	2002-08-28	Thiazoloderivatives and pharmaceutical compositions containing them and process for preparation the compounds
IL148517A0 (en)	2002-09-12	Heterocyclic compounds and pharmaceutical compositions containing the same
HUP0003859A3 (en)	2005-09-28	Imidazole fused heterocyclic compounds, process for their preparation, pharmaceutical compositions containing the same and their use
HUP0203183A3 (en)	2006-02-28	Novel heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use
IL150077A0 (en)	2002-12-01	Heterocyclic compounds and pharmaceutical compositions containing the same
HUP0203766A3 (en)	2008-01-28	5-pyridyl-1,3-azole compounds, process for producing the same and use thereof and pharmaceutical compositions containing them
HUP0200803A3 (en)	2002-12-28	Substituted bicyclic heteroaryl compounds as integrin antagonists, pharmaceutical compositions containing them and the intermediates
HUP0200714A3 (en)	2003-01-28	Pharmaceutical compounds, pharmaceutical compositions containing them and their use
HUP0204226A3 (en)	2003-07-28	Quinazoline derivatives, pharmaceutical compositions containing them, their use and process for the preparation of the compounds
HUP0203052A3 (en)	2004-06-28	Bicyclic imidazo-3-yl-amine derivatives, process for their preparation, pharmaceutical compositions containing them and their use
HUP0203107A3 (en)	2004-06-28	Novel spiro compounds, process for their preparation and pharmaceutical compositions containing them
IL145071A0 (en)	2002-06-30	Fused ring compounds and pharmaceutical compositions containing the same
HUP0003844A3 (en)	2002-11-28	Novel spiroazabicyclic heterocyclic compounds, process for their preparation, their use and pharmaceutical compositions containing them
IL144501A0 (en)	2002-05-23	Epothilone derivatives, methods for the preparation thereof and pharmaceutical compositions containing the same
HUP0201122A2 (en)	2002-08-28	Pyrimidinone compounds, process for their preparation and pharmaceutical compositions containing them
HUP0203140A3 (en)	2004-06-28	Bicyclic imidazo-5-yl-amine derivatives, process for their preparation and pharmaceutical compositions containing them
IL146104A0 (en)	2002-07-25	Substituted bicyclic heterocyclic compounds, processes for their preparation and pharmaceutical compositions containing the same
IL149883A0 (en)	2002-11-10	Heterocyclic compounds and pharmaceutical compositions containing the same
IL139480A0 (en)	2001-11-25	Epothilone derivatives, processes for the preparation thereof and pharmaceutical compositions containing the same
HUP0201714A2 (en)	2002-10-28	Substituted heterocyclic compounds and pharmaceutical compositions containing them
HUP0203739A3 (en)	2004-07-28	Bicyclic imidazo-3-yl-amine derivatives which are substituted on the sixth ring, process for their preparation and pharmaceutical compositions containing them